These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart. Farkas A, Qureshi A, Curtis MJ. Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833 [Abstract] [Full Text] [Related]
5. Limited antifibrillatory effectiveness of clinically relevant concentrations of class I antiarrhythmics in isolated perfused rat hearts. Farkas A, Curtis MJ. J Cardiovasc Pharmacol; 2002 Mar; 39(3):412-24. PubMed ID: 11862121 [Abstract] [Full Text] [Related]
6. Susceptibility to ischemia-induced ventricular fibrillation in isolated female rat hearts varies moderately with estrous cycle stage. Hatcher AS, Clements-Jewery H. J Pharmacol Toxicol Methods; 2013 Mar; 67(3):134-9. PubMed ID: 23357189 [Abstract] [Full Text] [Related]
7. Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. Curtis MJ, Hearse DJ. J Mol Cell Cardiol; 1989 Jan; 21(1):21-40. PubMed ID: 2716065 [Abstract] [Full Text] [Related]
9. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart. Hearse DJ, Ferrari R, Sutherland FJ. J Mol Cell Cardiol; 1999 Nov; 31(11):1961-73. PubMed ID: 10591023 [Abstract] [Full Text] [Related]
10. Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation. Stables CL, Curtis MJ. Cardiovasc Res; 2009 Jul 15; 83(2):397-404. PubMed ID: 19228704 [Abstract] [Full Text] [Related]
11. Susceptibility to ischemia-induced arrhythmias and the effect of preconditioning in the diabetic rat heart. Ravingerová T, Stetka R, Pancza D, Ulicná O, Ziegelhöffer A, Styk J. Physiol Res; 2000 Jul 15; 49(5):607-16. PubMed ID: 11191365 [Abstract] [Full Text] [Related]
13. Influence of extracellular potassium on the antiarrhythmic effect of global preconditioning in isolated perfused rat hearts. Feng J, Chahine R, Nadeau R. Mol Cell Biochem; 2000 Nov 15; 214(1-2):75-80. PubMed ID: 11195793 [Abstract] [Full Text] [Related]
14. Trapped platelets activated in ischemia initiate ventricular fibrillation. Dhanjal TS, Medina RA, Leem J, Clark JE, Southworth R, Curtis MJ. Circ Arrhythm Electrophysiol; 2013 Oct 15; 6(5):995-1001. PubMed ID: 23995251 [Abstract] [Full Text] [Related]
16. Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischaemia and reperfusion in isolated rat heart. Bril A, Laville MP, Gout B. Cardiovasc Res; 1992 Nov 15; 26(11):1069-76. PubMed ID: 1291084 [Abstract] [Full Text] [Related]
17. Mechanical conversion of post-ischaemic ventricular fibrillation: effects on function and myocyte injury in isolated rat hearts. Kawakami T, Löwbeer C, Valen G, Vaage J. Scand J Clin Lab Invest; 1999 Feb 15; 59(1):9-16. PubMed ID: 10206093 [Abstract] [Full Text] [Related]
18. Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts. Koltai M, Tosaki A, Hosford D, Esanu A, Braquet P. Cardiovasc Res; 1991 May 15; 25(5):391-7. PubMed ID: 1855244 [Abstract] [Full Text] [Related]
20. Anti-arrhythmic protection by ischaemic preconditioning in isolated rat hearts is not due to depletion of endogenous catecholamines. Lawson CS, Hearse DJ. Cardiovasc Res; 1996 Apr 15; 31(4):655-62. PubMed ID: 8689659 [Abstract] [Full Text] [Related] Page: [Next] [New Search]